Some people do it out of wanting to help move towards a cure for cancer, but in the case of our trial the patients will be getting a drug (doxorubicin) that is known to be efficacious in their cancer AND they are getting a dose of RC220 that is cardioprotective and has additive anticancer activity on top of doxorubicin from the preclinical studies. If it wasn't for the new formulation this trial would be a Phase 2 trial.
Some people do it out of wanting to help move towards a cure for...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.005(0.44%) |
Mkt cap ! $196.3M | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.12 | $202.7K | 178.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22685 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 12644 | 3 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |